Treatment of metastatic castration-resistant prostate cancer with niraparib

The present invention relates to a method of improving the efficacy of a treatment of 2 + line metastatic castration resistant prostate cancer (mCRPC) with a biallele DNA repair anomaly selected from the group consisting of: i) BRCA (BRCA1, BRCA2, or a combination thereof), ii) non-BRCA (ATM, FANCA,...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	DEL CORAL ALEJANDRO A, MASON GARY E, FRANCIS PAUL, ZHU YUANGEN, THOMAS, STEPHEN, N.A.HUTNIK, LOPEZ-GITELIZ ANA MARIA, ZHAO XIN, GORMLEY MICHAEL P, UTISCHAK KARL ANDREAS
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!